Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.20.2
Equity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Stock Options [Member]  
Number of Shares  
Outstanding, Beginning 11,385
Granted
Cancelled/Expired (324)
Outstanding, Ending 11,061
Exercisable 5,278
Weighted Average Exercise Price  
Outstanding, Beginning | $ / shares $ 1.17
Cancelled/Expired | $ / shares 0.55
Outstanding, Ending | $ / shares 1.19
Exercisable | $ / shares $ 2.00
Weighted Average Remaining Contractual Term (in years)  
Outstanding, Beginning 7 years 10 months 17 days
Outstanding, Ending 7 years 9 months 7 days
Exercisable 6 years 7 months 10 days
Aggregate Intrinsic Value  
Outstanding, Beginning | $
Outstanding, Ending | $
Exercisable | $
Warrant [Member]  
Number of Shares  
Outstanding, Beginning 86,141
Granted
Exercised
Cancelled/Expired
Outstanding, Ending 86,141
Exercisable 85,934
Weighted Average Exercise Price  
Outstanding, Beginning | $ / shares $ 0.69
Granted | $ / shares
Exercised | $ / shares
Cancelled/Expired | $ / shares
Outstanding, Ending | $ / shares 0.69
Exercisable | $ / shares $ 0.68
Weighted Average Remaining Contractual Term (in years)  
Outstanding, Beginning 2 years 11 months 12 days
Outstanding, Ending 2 years 8 months 12 days
Exercisable 2 years 8 months 12 days
Aggregate Intrinsic Value  
Outstanding, Beginning | $ $ 301
Outstanding, Ending | $ 267
Exercisable | $ $ 267